Brief Summary
The goal of this imaging study is to evaluate and improve the treatment planning techniques for abdominal radiation therapy. To accurately treat a tumor with radiation, Computed Tomography (CT) and Magnetic Resonance Images (MRI) are used to distinguish a tumor from normal, healthy tissue. However the quality of these images can be distorted by motion from breathing. To decrease motion, a patient may be asked to hold their breath or compress the abdomen, but currently there is no standard or best management option for all patients.
This study will explore the use continuous positive airway pressure (CPAP), a pressurized breathing mask, during MRI or CT imaging to decrease motion in the abdomen and produce higher quality images. With these additional images, we will also explore the feasibility of creating treatment plans using the CPAP MRI images alone.
This study will explore the use continuous positive airway pressure (CPAP), a pressurized breathing mask, during MRI or CT imaging to decrease motion in the abdomen and produce higher quality images. With these additional images, we will also explore the feasibility of creating treatment plans using the CPAP MRI images alone.
Brief Title
MRI Only Radiation Therapy With CPAP
Detailed Description
Patients will undergo both CT and MRI prior to abdominal radiation therapy and CBCT and orthogonal kV/MV images prior to each treatment delivery. A two arm study will be performed and patients will be enrolled into a given arm according to their eligibility. Arm 1 is for patients that are either not eligible for CPAP or that are unable to tolerate CPAP. These patients will undergo breath-hold and 4D imaging for both CT and MRI without CPAP. Arm 2 is for patients that are eligible for CPAP and able to tolerate CPAP. These patients will undergo breath-hold CT without CPAP, 4D-CT with and without CPAP and 4D-MRI with CPAP. Two specific aims will be investigated. In Aim 1, we will explore the feasibility of using a MRI-only in Radiation Oncology workflow. A probabilistic classification method will be utilized to generate a pseudo-CT from MRI to support treatment planning and image guidance for radiation therapy. The quality of the pseudo-CT will be evaluated by comparing it with CT. In addition, the reverse mapping will be investigated to create pseudo-MRI from CBCT to improve visualization of treatment targets and soft tissue prior to treatment delivery. In Aim 2, we will evaluate the utility of CPAP as a novel motion reduction methodology for patients with liver and pancreas cancer, to this end CT images with and without CPAP will be used. The evaluation will be based on the changes of motion magnitude, the achievable volumetric reduction in treatment target volumes, and doses to the targets and critical organs.
Categories
Completion Date
Completion Date Type
Actual
Conditions
Carcinoma Liver
Carcinoma, Pancreatic
Eligibility Criteria
Inclusion Criteria:
* Patients have liver or pancreas tumors (either primary tumors or metastases) and are scheduled to be treated with radiotherapy (either 3D conformal or intensity-modulation radiotherapy (IMRT) with conventional or hypo- fractionation).
* KPS \> 70
* If a biopsy is performed, the patient is at least 1 week post-biopsy.
* The patient's age must exceed 18 years.
* The patients must be able to commit to T1-weighted, T2-weighted, Dixon fat and water, ultrashort-TE, and other clinical or research MR sequence images prior to treatment.
* CPAP Eligibility: CPAP is a safe, effective form of therapy with rare complications. Relative contraindications include patients with bullous lung disease, fibrotic lung disease, Claustrophobia and recurrent sinus or ear infections. The absolute contraindications include obtundation /unconsciousness, chest wall trauma, suspected pneumothorax, persistent nausea/vomiting, active upper GI bleeding, history of recent gastric surgery, facial anomalies/trauma \[15,16\]. If there is any question about the above history and medical problems, the subject will be referred to a pulmonologist for consultation.
* The patients with above contraindications are not CPAP eligible and are enrolled in Arm 1 for the protocol without CPAP
* The eligible patients are enrolled in Arm 2 for the protocol with CPAP.
Exclusion Criteria:
* Any medical condition, which would make the imaging studies unsafe or poorly tolerated
* Known allergic reaction to contrast or shellfish
* Implanted metal devices or foreign bodies that serve as a contraindication to MR imaging
* Creatinine \> 1.4 mg/dl and Creatinine clearance \< 20 mg/dl.
* Uncontrolled, clinically significant cardiac arrhythmias
* Severe claustrophobia
* Pregnant female
* KPS \<70
* Patients have liver or pancreas tumors (either primary tumors or metastases) and are scheduled to be treated with radiotherapy (either 3D conformal or intensity-modulation radiotherapy (IMRT) with conventional or hypo- fractionation).
* KPS \> 70
* If a biopsy is performed, the patient is at least 1 week post-biopsy.
* The patient's age must exceed 18 years.
* The patients must be able to commit to T1-weighted, T2-weighted, Dixon fat and water, ultrashort-TE, and other clinical or research MR sequence images prior to treatment.
* CPAP Eligibility: CPAP is a safe, effective form of therapy with rare complications. Relative contraindications include patients with bullous lung disease, fibrotic lung disease, Claustrophobia and recurrent sinus or ear infections. The absolute contraindications include obtundation /unconsciousness, chest wall trauma, suspected pneumothorax, persistent nausea/vomiting, active upper GI bleeding, history of recent gastric surgery, facial anomalies/trauma \[15,16\]. If there is any question about the above history and medical problems, the subject will be referred to a pulmonologist for consultation.
* The patients with above contraindications are not CPAP eligible and are enrolled in Arm 1 for the protocol without CPAP
* The eligible patients are enrolled in Arm 2 for the protocol with CPAP.
Exclusion Criteria:
* Any medical condition, which would make the imaging studies unsafe or poorly tolerated
* Known allergic reaction to contrast or shellfish
* Implanted metal devices or foreign bodies that serve as a contraindication to MR imaging
* Creatinine \> 1.4 mg/dl and Creatinine clearance \< 20 mg/dl.
* Uncontrolled, clinically significant cardiac arrhythmias
* Severe claustrophobia
* Pregnant female
* KPS \<70
Inclusion Criteria
Inclusion Criteria:
* Patients have liver or pancreas tumors (either primary tumors or metastases) and are scheduled to be treated with radiotherapy (either 3D conformal or intensity-modulation radiotherapy (IMRT) with conventional or hypo- fractionation).
* KPS \> 70
* If a biopsy is performed, the patient is at least 1 week post-biopsy.
* The patient's age must exceed 18 years.
* The patients must be able to commit to T1-weighted, T2-weighted, Dixon fat and water, ultrashort-TE, and other clinical or research MR sequence images prior to treatment.
* CPAP Eligibility: CPAP is a safe, effective form of therapy with rare complications. Relative contraindications include patients with bullous lung disease, fibrotic lung disease, Claustrophobia and recurrent sinus or ear infections. The absolute contraindications include obtundation /unconsciousness, chest wall trauma, suspected pneumothorax, persistent nausea/vomiting, active upper GI bleeding, history of recent gastric surgery, facial anomalies/trauma \[15,16\]. If there is any question about the above history and medical problems, the subject will be referred to a pulmonologist for consultation.
* The patients with above contraindications are not CPAP eligible and are enrolled in Arm 1 for the protocol without CPAP
* The eligible patients are enrolled in Arm 2 for the protocol with CPAP.
* Patients have liver or pancreas tumors (either primary tumors or metastases) and are scheduled to be treated with radiotherapy (either 3D conformal or intensity-modulation radiotherapy (IMRT) with conventional or hypo- fractionation).
* KPS \> 70
* If a biopsy is performed, the patient is at least 1 week post-biopsy.
* The patient's age must exceed 18 years.
* The patients must be able to commit to T1-weighted, T2-weighted, Dixon fat and water, ultrashort-TE, and other clinical or research MR sequence images prior to treatment.
* CPAP Eligibility: CPAP is a safe, effective form of therapy with rare complications. Relative contraindications include patients with bullous lung disease, fibrotic lung disease, Claustrophobia and recurrent sinus or ear infections. The absolute contraindications include obtundation /unconsciousness, chest wall trauma, suspected pneumothorax, persistent nausea/vomiting, active upper GI bleeding, history of recent gastric surgery, facial anomalies/trauma \[15,16\]. If there is any question about the above history and medical problems, the subject will be referred to a pulmonologist for consultation.
* The patients with above contraindications are not CPAP eligible and are enrolled in Arm 1 for the protocol without CPAP
* The eligible patients are enrolled in Arm 2 for the protocol with CPAP.
Gender
All
Gender Based
false
Healthy Volunteers
No
Last Update Post Date
Last Update Post Date Type
Actual
Last Update Submit Date
Minimum Age
18 Years
NCT Id
NCT03397342
Org Class
Other
Org Full Name
Albert Einstein College of Medicine
Org Study Id
2017-7745
Overall Status
Terminated
Phases
Not Applicable
Primary Completion Date
Primary Completion Date Type
Actual
Official Title
MRI-only Radiation Therapy Workflow With Continuous Positive Airway Pressure (CPAP) for Motion Management in the Abdomen
Primary Outcomes
Outcome Description
The primary endpoint of aim 1 is that for the subjects enrolled in the study there is no statistically significant difference in ITV (internal target volumes) between subjects whose treatment is planned with MRI compared to subjects whose treatment is planned with 4D-CT.
Outcome Measure
Assessment of the Internal Target Volume on 4D-MR and 4D-CT
Outcome Time Frame
baseline
Outcome Description
The primary end point of aim 2 is that for the subjects enrolled in Continuous Positive Airway Pressure (CPAP) arm an average tumor motion reduction of at least 12% can be achieved when CPAP is used compared to free breathing.
Outcome Measure
Reduction of Tumor Motion Using Continuous Positive Airway Pressure
Outcome Time Frame
baseline
Start Date
Start Date Type
Actual
Status Verified Date
First Post Date
First Post Date Type
Actual
First Submit Date
First Submit QC Date
Std Ages
Adult
Older Adult
Maximum Age Number (converted to Years and rounded down)
999
Minimum Age Number (converted to Years and rounded down)
18
Investigators
Investigator Type
Principal Investigator
Investigator Name
Madhur Garg
Investigator Email
mgarg@montefiore.org
Investigator Phone
Categories Mesh Debug
Gastrointestinal (GI) Cancers --- DIGESTIVE SYSTEM NEOPLASMS
Cancer --- NEOPLASMS BY SITE
Cancer --- NEOPLASMS
Gastrointestinal (GI) Cancers --- DIGESTIVE SYSTEM DISEASES
Digestive System --- DIGESTIVE SYSTEM DISEASES
Liver --- DIGESTIVE SYSTEM DISEASES
Digestive System --- LIVER DISEASES
Liver --- LIVER DISEASES
Endocrine System Cancers --- ENDOCRINE GLAND NEOPLASMS
Endocrine System Cancers --- ENDOCRINE SYSTEM DISEASES
Diabetes --- ENDOCRINE SYSTEM DISEASES
Diabetes & Endocrine System --- ENDOCRINE SYSTEM DISEASES
MeSH Terms
LIVER NEOPLASMS
PANCREATIC NEOPLASMS
DIGESTIVE SYSTEM NEOPLASMS
NEOPLASMS BY SITE
NEOPLASMS
DIGESTIVE SYSTEM DISEASES
LIVER DISEASES
ENDOCRINE GLAND NEOPLASMS
PANCREATIC DISEASES
ENDOCRINE SYSTEM DISEASES